Evidence map›Paper›PMID 41542435›Full record

ArticlebioRxiv : the preprint server for biology2026

Retrograde transduction of dopaminergic cells in substantia nigra of rhesus monkey.

Anya S Plotnikova, Walter Lerchner, Alexander C Cummins, Gang Chen, Leonardo Salhani, Vincent D Costa, Bruno B Averbeck, Barry J Richmond, Zayd M Khaliq, Mark A G Eldridge

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Anya S PlotnikovaLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0009-0000-2451-5939
Walter LerchnerLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-0842-4409
Alexander C CumminsLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Gang ChenScientific and Statistical Computing Core, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, United States.ORCID 0000-0002-2960-089X
Leonardo SalhaniLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Vincent D CostaLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-5412-8945
Bruno B AverbeckLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-3976-8565
Barry J RichmondLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-8234-1540
Zayd M KhaliqCellular Neurophysiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-1445-1457
Mark A G EldridgeLaboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0003-4292-6832

Funding

NEURAL MECHANISMS OF MOTIVATION AND REWARDZ01MH002619 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI RICHMOND, BARRY J · 1992 to 2008
$2.7M
Intramural NIH HHS Z01 MH002619
6 · The paper itself

Abstract

Neuromodulatory systems regulate neural circuits across broad regions of the brain, and disruption of the dopaminergic system contributes to psychiatric and neurodegenerative disorders. Engineered viral vectors have been used to target the neuromodulatory systems of the nonhuman primate brain (Y. Chen et al., 2023; El-Shamayleh et al., 2016; Gray et al., 2010; Lerchner et al., 2014; Perez et al., 2022). However, a conspicuous obstacle to the isolation and modulation of specific pathways is the inability of many retrogradely infecting viruses to transduce dopaminergic (DA) cells efficiently (Tervo et al., 2016; Cushnie et al., 2020; Weiss et al., 2020). We compare the DA neuron retrograde transduction efficacy of four viral vectors after injection into the striatum of nonhuman primates (NHP). Selectivity was assessed by comparing the neuronal co-expression of fluorescent reporter protein and tyrosine-hydroxylase (TH) antibody in substantia nigra pars compacta (SNc). The rabies pseudotyped lentiviral vector, FuG-B2, produced superior retrograde transduction of DA cells to FuG-C or FuG-E. AAV2.retro was the least effective.

Indexed as

Dopamine cellsLentivirusRetrogradeRhesus macaqueStriatumSubstantia NigraTransduction

Identifiers

PMID41542435
PMCPMC12803195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.